VERRUCAE TREATED BY LEVAMISOLE
VERRUCAE TREATED BY LEVAMISOLE
复制标题
DOI：
10.1111/j.1365-4362.1991.tb02624.x
复制
发表时间：
1991-10-01
影响因子：
3.6
通讯作者：
ALGENDY, AA
中科院分区：
文献类型：
--
作者：
AMER, M;TOSSON, Z;ALGENDY, AA
为了评估左旋咪唑在治疗不同类型疣中的作用，对40名患有不同类型疣的患者进行了双盲研究。 患者被分为两个相等的组，A和B。 A组给予左旋咪唑5 mg/kg体重，连续3天，每2周1次，共5个月，B组给予安慰剂。 在A组中，12例患者显示完全治愈（60%），2例显示部分治愈（10%），其余6例患者显示无反应（30%）。 B组仅1例完全治愈。 平面疣和普通疣的治愈率较高，而足底疣用左旋咪唑治疗无改善。
To assess the role of levamisole in treatment of different types of warts, a double-blind study was conducted on 40 patients with different types of warts. Patients were divided into two equal groups, A and B. Group A received levamisole 5 mg/kg body weight on 3 consecutive days every 2 weeks for a period up to 5 months, while patients of group B received placebo for the same period. In group A, 12 patients showed complete cure (60%), two showed partial cure (10%), and the remaining six patients showed no response (30%). In group B, complete cure was achieved only in one case. The higher cure rate was observed in plane and common warts, while plantar warts showed no improvement with levamisole treatment.